RE:RE:Westcoast --thanks for your posts...questionThank you! Very candid and objective post.
westcoast1000 wrote: HC,
In response to your questions, I have been in this stock for about 7 years. My initial purchase was at about $4/share pre split, so about $40 today. I bought a lot of stock below $2 post split, and so managed to average down enough to be modestly in the green today. I do not work in biotech, but I do understand statistics and clinical trials to a reasonable degree.I am not a physician or life sciences type. No one is an expert on all aspects of this stock, because it covers too many areas. I certainly have read a lot of material on this stock and followed all the calls. Canadafan and CAPC also have paid close attention to how the stock and its trials have evolved.
Matt Coffey gives very informative talks that allow listeners to learn about what the regulators have told them and how their views have evolved over the last few years. In some sense, it is sheer luck that science has evolved to the point where ONCY has far more potential now than 20 years ago when it started out. the virus has not changed but our understanding of what it can do, particularly with checkpoint inhibitors has changed enormously.
All investors should recall this is a biotech with only one product, that is still in clinical trials. Yet the only two things between today and fabulous wealth for share owners is good clinical results and the ability to strike a partnership. On the trials front, things have never looked better. On the partner front, we now have a lot of interested big pharmas working with us.